| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18513 R78664 |
Zafeiri, 2022 | Neural tube defects | during pregnancy (anytime or not specified) excluded | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy |
1.21 [0.71;2.06] excluded (exposition period) |
22/24,099 50/107,143 | 72 | 24,099 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18501 R79019 |
Feldkamp, 2010 | Neural tube defects | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.10 [0.92;1.30] | 339/2,295 371/2,558 | 710 | 2,295 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18639 R79216 |
Pérez-Molina, 2002 | High neural tube defects (anencephaly, encephalocele, myelocele, meningocele, or myelomeningocele occurred at or above the 11th thoracic vertebra (T11)) | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Paracetamol use: maternal ITW/questionnaires after pregnancy | 5.20 [0.58;119.60] | 5/- 102/- | 107 | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 2 studies | 1.32 [0.49;3.54] | 817 | 2,295 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded